This document can be used to prepare or evaluate feasibility of ancillary study proposals and paper proposals, but is NOT intended for publication.

Form 54 - Change of Medications

File NameData as ofPopulationData collectedOne row perRows
f54_ct_inv.dat9/12/2005CTMainForm48,589
ID - WHI Participant Common ID
Col 1
NMissing
48,5890
F54DAYS - F54 Days since CT randomization
Col 2
NMissingMinMaxMeanStdDev
48,589023,9131,158.976782.316
F54CADDY - F54 Days since CaD randomization
Col 3
Days between CaD randomization and initiation of form
NMissingMinMaxMeanStdDev
37,40511,184-7413,440833.606781.538
F54VTYP - Visit Type
Col 4
ValueDescriptionN%
1Screening00
2Semi-Annual visit9,83820.2
3Annual visit12,21025.1
4Non-Routine visit26,51654.6
56 week HRT/4 week CaD call250.1
6Diet Intervention00
7Interim 33/33D00
8Amendment 33/33D00
F54VY - Visit year
Col 5
Visit year for which this form was collected.
NMissingMinMaxMeanStdDev
22,04826,5411113.8232.076
HRT - HRT dosage (pills/week)
Col 6
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) HRT dosage (pills/week):
NMissingMinMaxMeanStdDev
28,08020,5090143.7913.341
CEE3 - CEE 0.3mg dosage (pills/week)
Col 7
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) CEE 0.3 mg dosage (pills/week):
NMissingMinMaxMeanStdDev
49248,0970144.6293.37
CEE625 - CEE 0.625 mg dosage (pills/week)
Col 8
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) CEE 0.625 mg dosage (pills/week):
NMissingMinMaxMeanStdDev
44148,1480144.3633.488
MPA25 - MPA 2.5 mg dosage (pills/week)
Col 9
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) MPA 2.5 mg dosage (pills/week):
NMissingMinMaxMeanStdDev
4,01444,5750566.5534.418
MPA5 - MPA 5 mg dosage (pills/week)
Col 10
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) MPA 5 mg dosage (pills/week):
NMissingMinMaxMeanStdDev
50048,0890285.873.203
MPA10 - MPA 10 mg dosage (pills/week)
Col 11
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) MPA 10 mg dosage (pills/week):
NMissingMinMaxMeanStdDev
1,20247,3870216.2044.149
CAD - CaD dosage (pills/week)
Col 12
What is the new study medication schedule? (Include all study medications the participant should take, including those that you are not changing.) CaD dosage (pills/week):
NMissingMinMaxMeanStdDev
28,15220,4370146.7495.687
CYCLIC - Cyclic regimen
Col 13
Is this a cyclic regimen?
Usage Notes: Not collected on all versions of Form 54.
ValueDescriptionN%
0No16,78634.5
1Yes5061
Missing31,29764.4%
PERM - Study medication permanent
Col 14
Is the new study medication schedule permanent?
ValueDescriptionN%
0No24,02249.4
1Yes23,97849.3
Missing5891.2%
HOWLONG - How long to take (weeks)
Col 15
For how long should the participant follow this new study medication schedule? (Record shortest length of time if more than one medication.)
Usage Notes: Sub-question of F54 V3 Q7 "Study medication permanent" (skip pattern rule not applied).
NMissingMinMaxMeanStdDev
23,04625,5430529.337.755
HRTBLEED - HRT - bleeding
Col 16
Why did you make the change in the medication schedule? (Mark all that apply). HRT - bleeding:
ValueDescriptionN%
0No18,94939
1Yes5,75111.8
Missing23,88949.2%
HRTBIOP - HRT - biopsy abnormality
Col 17
Why did you make the change in the medication schedule? (Mark all that apply). HRT - biopsy abnormality:
ValueDescriptionN%
0No24,48150.4
1Yes2190.5
Missing23,88949.2%
HRTTVU - HRT - abnormal transvaginal ultrasound
Col 18
Why did you make the change in the medication schedule? (Mark all that apply). HRT - abnormal transvaginal ultrasound:
ValueDescriptionN%
0No24,61150.7
1Yes890.2
Missing23,88949.2%
HRTSYMP - HRT - symptom intolerance
Col 19
Why did you make the change in the medication schedule? (Mark all that apply). HRT - symptom intolerance:
ValueDescriptionN%
0No19,96441.1
1Yes4,7369.7
Missing23,88949.2%
HRTOTHER - HRT - other
Col 20
Why did you make the change in the medication schedule? (Mark all that apply). HRT - other:
ValueDescriptionN%
0No9,51519.6
1Yes15,18531.3
Missing23,88949.2%
CADSYMP - CaD - symptom intolerance
Col 21
Why did you make the change in the medication schedule? (Mark all that apply). CAD - symptom intolerance:
ValueDescriptionN%
0No13,81228.4
1Yes8,86718.2
Missing25,91053.3%
CADOTHER - CaD - other
Col 22
Why did you make the change in the medication schedule? (Mark all that apply). CAD - other:
ValueDescriptionN%
0No8,19416.9
1Yes14,48529.8
Missing25,91053.3%